SCHEMBL22072519

SCHEMBL22072519

CCc1oc2c(O)c(O)c(O)c(O)c2c1C(=O)c1cc(Br)c(OC(C)=O)c(Br)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 7/20 0.46
▸ SLC22A12 Q96S37 10/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ NR1H4 Q96RI1 4/20 0.45
▸ EYA3 Q99504 3/20 0.45
▸ CYP2C9 P11712 2/20 0.45
▸ EYA2 O00167 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ ABCC4 O15439 1/20 0.45
▸ PLIN1 O60240 1/20 0.45
▸ NR1I2 O75469 1/20 0.45
▸ USP2 O75604 1/20 0.45
▸ ABCB11 O95342 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ ALB P02768 1/20 0.45
▸ ESR1 P03372 1/20 0.45
▸ NR3C1 P04150 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ PGR P06401 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22680479 0.91 TTR (0.43) TTRSLC22A12CYP2C19NR1H4EYA3
SCHEMBL26211318 0.86 SLC22A12 (0.57) TTRSLC22A12CYP2C19NR1H4EYA3
SCHEMBL26211986 0.84 SLC22A12 (0.54) TTRSLC22A12CYP2C19NR1H4EYA3
SCHEMBL26212284 0.83 TTR (0.47) TTRSLC22A12CYP2C19NR1H4EYA3
SCHEMBL24221837 0.83 CYP2C19 (0.47) TTRSLC22A12CYP2C19NR1H4EYA3
SCHEMBL24102976 0.82 CYP2C19 (0.46) TTRSLC22A12CYP2C19NR1H4EYA3
SCHEMBL24266787 0.81 EYA3 (0.36) TTRSLC22A12CYP2C19NR1H4EYA3
SCHEMBL26211216 0.77 SLC22A12 (0.53) TTRSLC22A12CYP2C19NR1H4EYA3
SCHEMBL22072520 0.76 SLC22A12 (0.55) TTRSLC22A12EYA3CYP2C9ESR1
SCHEMBL25815022 0.74 CYP2C19 (0.79) TTRSLC22A12CYP2C19NR1H4EYA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3957629-B1 PROCESS FOR MAKING DEUTERATED HYDROXY-BENZBROMARONE AND INTERMEDIATES THEREOF ARTHROSI THERAPEUTICS INC (US) 2023-09-06 — — EP disclosed
WO-2023098872-A1 CRYSTALLINE FORMS OF A COMPOUND FOR TREATING OR PREVENTING GOUT OR HYPERURICEMIA ARTHROSI THERAPEUTICS, INC. (US) 2023-06-08 — — WO disclosed
WO-2020118114-A1 METHODS FOR TREATING OR PREVENTING GOUT OR HYPERURICEMIA ARTHROSI THERAPEUTICS, INC. (US) 2020-06-11 — — WO disclosed
WO-2020118113-A1 CRYSTALLINE FORMS OF A COMPOUND FOR TREATING OR PREVENTING GOUT OR HYPERURICEMIA ARTHROSI THERAPEUTICS, INC. (US) 2020-06-11 — — WO disclosed
Send feedback